Trials / Conditions / Schizophrenia and Disorders With Psychotic Features

Schizophrenia and Disorders With Psychotic Features

19 registered clinical trials studyying Schizophrenia and Disorders With Psychotic Features — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder NCT06939088	Anders Fink-Jensen, MD, DMSci	Phase 2
Completed	Video Games Among People With Schizophrenia NCT03133143	The Hong Kong Polytechnic University	N/A
Completed	Effectiveness of a Mindfulness-based Group Training Addressing Social Cognition in First Episode Psychosis (AG NCT03309475	Instituto de Investigación Hospital Universitario La Paz	N/A
Unknown	Antipsychotic Effects of Sorghum Bicolor (JOBELYN) in the Treatment of Schizophrenia NCT02240173	Federal Neuro-Psychiatric Hospital, Yaba	Phase 1 / Phase 2
Completed	Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patien NCT02307396	Technical University of Munich	Phase 4
Completed	Anomalous Self-Experience in First Episode Psychosis - A Six-Year Follow-Up Study NCT02321943	Sykehuset Innlandet HF	—
Completed	Implementation and Evaluation of a Family-based Intervention Program for Children of Mentally Ill Parents NCT02308462	Silke Wiegand-Grefe, Prof. Dr.	N/A
Unknown	Investigator Initiated Study - Asenapine Early Psychosis NCT01968161	Centre de Recherche de l'Institut Universitaire en Santé Mentale de Québec	Phase 4
Completed	The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and Mechanisms NCT02928965	University of Manchester	Phase 2
Recruiting	Karolinska Schizophrenia Project NCT06872463	Karolinska Institutet	—
Completed	Duration of Untreated Psychosis (DUP) and Pathways to Care in Nordland NCT01196858	University Hospital of North Norway	—
Unknown	Social Skills Training in Refractory Schizophrenia NCT00791882	University of Sao Paulo	N/A
Terminated	One-Year Trial Of Oral Ziprasidone In Patients With Metabolic Syndrome NCT00748566	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 4
Completed	Side Effects of Antipsychotic Medications NCT00363181	Stanford University	—
Completed	Specialized Treatment Early in Psychosis (STEP) NCT00309452	Yale University	N/A
Completed	Resource-oriented Music Therapy for Psychiatric Patients With Low Therapy Motivation NCT00137189	NORCE Norwegian Research Centre AS	N/A
Completed	Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2 NCT00135772	National Institute on Drug Abuse (NIDA)	—
Completed	Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia NCT00136760	Brown University	Phase 2
Completed	Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia NCT00218218	National Institute on Drug Abuse (NIDA)	Phase 2